Discover

STAA
STAAR Surgical Company
24.27
1 x 23.97
1 x 25.16
bid
ask
+
0.30
1.25%
50 @ 04:00 PM
24.35 +0.08 (0.33%)
Ytd5.11%
1y36.66%
23.37
day range
24.62
13.50
52 week range
49.86
Open23.97Prev Close23.97Low23.37High24.62Mkt Cap1.21B
Vol1.87MAvg Vol884.02KEPS-0.43P/E203.38Forward P/E114.94
Beta1.23Short Ratio8.45Inst. Own113.69%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg29.14200-d Avg24.461yr Est30.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-08-122026-070.21N/AN/AN/A
2026-05-132026-040.050.380.33600.85%
2026-03-032026-010.18-0.2-0.38-211.11%
2025-11-052025-090.180.460.28155.56%
2025-08-062025-06-0.56-0.070.4987.50%
2025-05-072025-03-0.59-0.520.0711.86%
Upgrade / Downgrade
DateFirmActionFromTo
2026-05-29WedbushUpgradeOutperformOutperform
2026-05-15Wells FargoUpgradeEqual-WeightEqual-Weight
2026-05-14Canaccord GenuityUpgradeBuyBuy
2026-05-14Piper SandlerUpgradeNeutralNeutral
2026-05-14StifelUpgradeHoldHold
2026-05-14WedbushUpgradeNeutralOutperform
Profile
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Insider Holder
DateNameRelationQuantityDescription
2026-05-14ANDREWS DEBORAH JChief Executive Officer18.65KStock Award(Grant)
2026-03-12BROADWOOD PARTNERS, L.P.Beneficial Owner of more than 10% of a Class of Security0.00Purchase
2026-06-17BUTCHER ARTHUR CDirector9.55KConversion of Exercise of derivative security
2025-03-04FARRELL STEPHEN CChief Executive Officer35.16KConversion of Exercise of derivative security
2026-05-14FOUST WARRENChief Executive Officer83.11KStock Award(Grant)
2026-06-17JIANG WEIDirector77.13KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30BROADWOOD CAPITAL Inc16.12M0.0032.38%
2026-03-30BlackRock Inc6.67M0.0013.39%
2025-12-30Vanguard Group Inc4.23M0.008.49%
2026-03-30Yunqi Capital Ltd3.26M0.006.54%
2026-03-30Madison Avenue Partners, LP2.44M0.004.90%
2026-03-30Vanguard Portfolio Management, LLC2.12M0.004.27%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29iShares Core S&P Small-Cap ETF3.00M0.006.03%
2026-06-29Vanguard Total Stock Mkt Idx Inv949.46K0.001.91%
2026-06-29iShares Russell 2000 ETF888.86K0.001.79%
2026-06-29Vanguard Small Cap Index683.43K0.001.37%
2026-06-29Vanguard Institutional Extnd Mkt Idx Tr570.54K0.001.15%
2026-06-29State Street SPDR Port S&P 600 Sm CpETF457.40K0.000.92%
Split
SplitDate
1 : 21992-05-18